Low-grade gliomas presenting with pharmaco-resistant epilepsy: a different subgroup of low-grade gliomas

K. Minkin, C. Tzekov, E. Naydenov, A. Bussarsky, V. Karakostov, M. Marinov, K. Romansky & V. Bussarsky
Objective: Patients with low-grade gliomas have 5-year survival rates from 42 to 92%. Patients with pharmaco-resistant epilepsy (PRE) due to LGG usually have a mean preoperative history of epilepsy longer than 10 years and some authors reported a 10-year postoperative recurrence free survival rate[for full text, please go to the a.m. URL]